Connect with us
96% of the biotech companies are SMEs or micro-SMEs, contributing minimally to the Spanish biotech sector revenues. Large firms, though only 4.1%, account for 37.9% of...
In 2023, Spanish biotech companies secured 228 million euros in private financing, a 37% increase from 2022. This was announced at the AseBio Investor Day, organized...
There are many companies in the biomedical sector that, being in the investment or expansion phase, have negative or reduced quotas. Given this particularity, what monetization...
Rovi announced that it estimates its operating income will decrease by around 10% compared to 2023. This forecast has been justified, mainly, by the fact that...
Spanish biotech companies maintain their leading position in the industrial sector in science with the highest percentage of researchers. The research workplaces Spain in the ninth position...
AstraZeneca’s commitment to the Spanish territory can also be seen in the creation of infrastructure since it has allocated a total of €5.5 million for the...